Final approval has been granted for a drug that treats a rare genetic condition that leads to joint pain and in some cases death. Nitisinone has been approved for use after trials showed it can halt the progress of Alkaptonuria (AKU) and provide hope for a pain free future. Julien Sireau was diagnosed with AKU 20 years ago and his family has dedicated his life to campaigning and fundraising to help find a cure.
Weedkiller drug could help thousands who suffer from ‘black bone disease’
